MTAC — Shareholder Vote
MedTech Acquisition Corporation · 2026-05-14
The two nominees for Directors were elected to serve three-year terms to expire at the annual meeting of stockholders in 2029, as follows:
Vote type
director election
Outcome
passed
Shares for
31,393,310
Shares against
2,614,246
Data sourced from SEC EDGAR filings. Dates reflect the vote/event date as disclosed in the filing. Outcomes updated when follow-up filings are published.